|
Cardiovascular Disease/ Myocardial Infarction
Citations 171-180 of 631 total displayed.
|
Past content
(since Feb 1998):
|
- Editor's Correspondence
Clinical Trials of Antioxidant Supplementation in the Prevention of Cardiovascular Events—Reply
- Nancy R. Cook; Christine M. Albert; JoAnn E. Manson; for the WACS Investigator Group
Arch Intern Med 2008; 168: 773-a-774-a.
[Extract]
[Full text]
- Editor's Correspondence
Clinical Trials of Antioxidant Supplementation in the Prevention of Cardiovascular Events
- Niki Katsiki; Christos Manes
Arch Intern Med 2008; 168: 773.
[Extract]
[Full text]
[PDF]
- Original Investigations
Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data
- Anna Bennet; Emanuele Di Angelantonio; Sebhat Erqou; Gudny Eiriksdottir; Gunnar Sigurdsson; Mark Woodward; Ann Rumley; Gordon D. O. Lowe; John Danesh; Vilmundur Gudnason
Arch Intern Med 2008; 168: 598-608.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Long-term Risk of Mortality and End-Stage Renal Disease Among the Elderly After Small Increases in Serum Creatinine Level During Hospitalization for Acute Myocardial Infarction
- Britt B. Newsome; David G. Warnock; William M. McClellan; Charles A. Herzog; Catarina I. Kiefe; Paul W. Eggers; Jeroan J. Allison
Arch Intern Med 2008; 168: 609-616.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Definition of Kidney Dysfunction as a Cardiovascular Risk Factor: Use of Urinary Albumin Excretion and Estimated Glomerular Filtration Rate
- Massimo Cirillo; Maria Paola Lanti; Alessandro Menotti; Martino Laurenzi; Mario Mancini; Alberto Zanchetti; Natale G. De Santo
Arch Intern Med 2008; 168: 617-624.
[Abstract]
[Full text]
[PDF]
- Original Investigations
A Randomized Trial of Direct-to-Patient Communication to Enhance Adherence to β-Blocker Therapy Following Myocardial Infarction
- David H. Smith; Judith M. Kramer; Nancy Perrin; Richard Platt; Douglas W. Roblin; Kimberly Lane; Michael Goodman; Winnie W. Nelson; Xiuhai Yang; Stephen B. Soumerai
Arch Intern Med 2008; 168: 477-483.
[Abstract]
[Full text]
[PDF]
- Invited Commentary
A Randomized Trial of Direct-to-Patient Communication to Enhance Adherence to β-Blocker Therapy Following Myocardial Infarction—Invited Commentary
- Edward P. Havranek
Arch Intern Med 2008; 168: 483.
[Extract]
[Full text]
[PDF]
- Original Investigations
Association of Early Follow-up After Acute Myocardial Infarction With Higher Rates of Medication Use
- Stacie L. Daugherty; P. Michael Ho; John A. Spertus; Philip G. Jones; Richard G. Bach; Harlan M. Krumholz; Eric D. Peterson; John S. Rumsfeld; Frederick A. Masoudi
Arch Intern Med 2008; 168: 485-491.
[Abstract]
[Full text]
[PDF]
- Invited Commentary
Association of Early Follow-up After Acute Myocardial Infarction With Higher Rates of Medication Use—Invited Commentary
- Elizabeth A. Jackson
Arch Intern Med 2008; 168: 492.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Laboratory-Defined Aspirin Resistance and Recurrent Cardiovascular Events
- Pierre Fontana; Jean-Luc Reny
Arch Intern Med 2008; 168: 549-550.
[Extract]
[Full text]
[PDF]
|
|
